Proteomic analysis of silver nanoparticle toxicity in rat

Toxicology and Environmental Health Sciences

Volumn 2, Issue 4, 2010, Pages 251-262

  Kim, Eunjoo ^a   Chu, Young Chae ^b   Han, Jee Young ^b   Lee, Don Haeng ^b,c   Kim, Ye Ji ^b   Kim, Hyun Chul ^a   Lee, Se Geun ^a   Lee, Sung Jun ^a   Jeong, Sang Won ^a   Kim, Joon Mee ^b  

^a Daegu Gyeongbuk Institute of Science and Technology   (South Korea)

^b Inha University Hospital   (South Korea)

^c Utah Inha DDS and Advanced Theapeutics Research Center   (South Korea)

Author keywords

Apoptosis; Biomarker; Blood coagulation; Reactive oxygen species; Silver nanoparticle; Toxicoproteomics

Indexed keywords

EID: 84873269949     PISSN: 20059752     EISSN: 22337784     Source Type: Journal    
DOI: 10.1007/BF03217491     Document Type: Article

References (82)

1. Marcato, P. D. & Durán, N. New aspects of nanopharmaceutical delivery systems. J. Nanosci. Nanotechnol. 8, 2216-2229 (2008).
2. Manocchi, A. K., Horelik, N. E., Lee, B. & Yi, H. Simple, readily controllable palladium nanoparticle formation on surface-assembled viral nanotemplates. Langmuir26, 3670-3677 (2010).
3. Maynard, A. D. A Research Strategy for Addressing Risk. In: Nanotechnology, Woodrow Wilson International Center for Scholars (2006).
4. Chen, X. et al. A novel testis protein, RSB-66, interacting with INCA1 (inhibitor of Cdk interacting with cyclin A1). Biochem. Cell. Biol. 86, 345-351 (2008).
5. Morones, J. R. et al. The bactericidal effect of silver nanoparticles. Nanotechnology16, 2346-2353 (2005).
6. White, R. J. An historical overview of the use of silver in wound management. Br. J. Nurs. 10, S3-8 (2001).
7. Sondi, I. & Salopek-Sondi, B. Silver nanoparticles as antimicrobial agent: A case study onE. coli as a model for Gram-negative bacteria. J. Colloid Interface Sci. 275, 177-182 (2004).
8. Kim, J. S. et al. Antimicrobial effects of silver nanoparticles. Nanomed. 3, 95-101 (2007).
9. Gade, A. K. et al. Exploitation of Aspergillus niger for fabrication of silver nanoparticles. J. Biobased. Mater. Bioenergy2, 243-247 (2008).
10. Raffi, M. et al. Antibacterial characterization of silver nanoparticles against E. coli ATCC-15224. J. Mater. Sci. Technol. 24, 192-196 (2008).
11. Lok, C. N. et al. Proteomic analysis of the mode of antibacterial action of silver nanoparticles. J. Proteome Res. 5, 916-924 (2006).
12. Hussain, S. M., Hess, K., Gearhart, J., Geiss, K. & Schlager, J. In vitro toxicity of nanoparticles in BRL3A rat liver cells. Toxicol. In vitro19, 975-983 (2005).
13. Carlson, C. et al. Unique cellular interaction of silver nanoparticles: size-dependent generation of reactive oxygen species. J. Phys. Chem. B112, 13608-13619 (2008).
14. Hussain, S. M. et al. The Interaction of manganese nanoparticles with PC-12 cells induces dopamine depletion. Toxicol. Sci. 92, 456-463 (2006).
15. Sung, J. H. et al. Subchronic inhalation toxicity of silver nanoparticles. Inhalation Toxicol. 20, 567-574 (2008).
16. Oberdorster, G. et al. Extrapulmonary translocation of ultrafine carbon particles following whole-body inhalation exposure of rats. J. Toxicol. Environ. Health Part A65, 1531-1543 (2002).
17. Oberdorster, G. Pulmonary effects of inhaled ultrafine particles. Int. Arch. Occup. Environ. Health74, 1-8 (2001).
18. Kreilgaard, M. Influence of microemulsions on cutaneous drug delivery. Adv. Drug Delivery Rev. 54, S77-98 (2002).
19. Sinha, A., Singh, C., Parmar, D. & Singh, M. P. Proteomics in clinical interventions: Achievements and limitations in biomarker development. Life Sci. 80, 1345-1354 (2007).
20. Fernandez, J., Gharahdaghi, F. & Mische, S. M. Routine identification of proteins from sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) gels or polyvinyl difluoride membranes using matrix assisted laser desorption/ionization-time of flight-mass spectrometry (MALDI-TOF-MS). Electrophoresis19, 1036-1045 (1998).
21. Braisted, J. C. et al. The APEX quantitative proteomics tool: generating protein quantitation estimates from LC-MS/MS proteomics results. BMC Bioinf. 9, 529-539 (2008).
22. Zhu, J. Y., Huang, H. Q., Bao, X. D., Lin, Q. M. & Cai, Z. Acute toxicity profile of cadmium revealed by proteomics in brain tissue ofParalichthys olivaceus: potential role of transferrin in cadmium toxicity. Aquat. Toxicol. 78, 127-135 (2006).
23. Kim, H. R. et al. Protein profiles of bovine placenta derived from somatic cell nuclear transfer. Proteomics5, 4264-4273 (2005).
24. Diederichs, S. et al. of interaction partners and substrates of the cyclin A1-CDK2 complex. J. Biol. Chem. 279, 33727-33741 (2004).
25. Peshavaria, M. & Day, I. N. Molecular structure of the human muscle-specific enolase gene (ENO3). Biochem. J. 275, 427-433 (1991).
26. Dinovo, E. C. & Boyer, P. D. Isotopic probes of the enolase reaction mechanism. J. Biol. Chem. 240, 4586-4593 (1971).
27. Loar, P. et al. Inhibition of glycolysis enhances cisplatin-induced apoptosis in ovarian cancer cells. Am. J. Obstet. Gynecol. 202, 371. e1-8 (2010).
28. Li, P. W., Kuo, T. H., Chang, J. H., Yeh, J. M. & Chan, W. H. Induction of cytotoxicity and apoptosis in mouse blastocysts by silver nanoparticles. Toxicol. Lett. 197, 82-87 (2010).
29. Miura, N. & Shinohara, Y. Cytotoxic effect and apoptosis induction by silver nanoparticles in HeLa cells. Biochem. Biophys. Res. Commun. 390, 733-737 (2009).
30. Lapied, E., Moudilou, E., Exbrayat, J. M., Oughton, H. & Joner, E. J. Silver nanoparticle exposure causes apoptotic response in the earthworm Lumbricus terrestris (Oligochaeta). Nanomed. 5, 975-984 (2010).
31. Feo, S., Arcuri, D., Piddini, E., Passantino, R. & Giallongo, A. ENO1 gene product binds to the c-myc promoter and acts as a transcriptional repressor: relationship with Myc promoter-binding protein 1 (MBP-1). FEBS Lett. 473, 47-52 (2000).
32. Higuti, T. et al. The complete amino acid sequence of subunit d of rat liver mitochondrial H(+)-ATP synthase. J. Biochem. 114, 714-717 (1991).
33. Horn, D. & Barrientos, A. Mitochondrial copper metabolism and delivery to cytochrome c oxidase. IUBMB life60, 421-429 (2008).
34. Ko, Y. H., Hullihen, J., Hong, S. & Pedersen, P. L. Mitochondrial F(0)F(1) ATP synthase. Subunit regions on the F1 motor shielded by F(0), Functional significance, and evidence for an involvement of the unique F(0) subunit F(6). J. Biol. Chem. 275, 32931-33939 (2000).
35. Das, A. M. Regulation of the mitochondrial ATP-synthase in health and disease. Mol. Genet. Metab. 79, 71-82 (2003).
36. AshaRani, P. V., Hande, M. P. & Valiyaveettil, S. Anti-proliferative activity of silver nanoparticles. BMC Cell Biol. 10, 65-78 (2009).
37. Kim, M. et al. Increased expression of the F1Fo ATP synthase in response to iron in heart mitochondria. BMB Rep. 41, 153-157 (2008).
38. AshaRani, P. V., Low Kah, M. G., Hande, M. P. & Valiyaveettil, S. Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano3, 279-290 (2009).
39. Tjelle, T. E., Lovdal, T. & Berg, T. Phagosome dynamics and function. Bioessays22, 255-263 (2000).
40. Nakanishi, H. & Takai, Y. Roles of nectins in cell adhesion, migration and polarization. Biol. Chem. 385, 885-892 (2004).
41. Stuart, L. M. & Ezekowitz, R. A. Phagocytosis: elegant complexity. Immunity22, 539-550 (2005).
42. Thomas, T. H. & Advani, A. Inflammation in cardiovascular disease and regulation of the actin cytoskeleton in inflammatory cells: the actin cytoskeleton as a target. Cardiovasc. Hematol. Agents Med. Chem. 4, 165-182 (2006).
43. Bastian, B. C. Annexins in cancer and autoimmune diseases. Cell. Mol. Life Sci. 53, 554-556 (1997).
44. 2+ signalling to membrane dynamics. Nat. Rev. Mol. Cell. Biol. 6, 449-461 (2006).
45. Moss, S. E. & Morgan, R. O. The annexins. Genome Biol. 5, 219-226 (2004). or46{pipe}Jun, E. A. et al. Silver nanoparticles enhance thrombus formation through increased platelet aggregation and procoagulant activity. Nanotoxicology in press, DOI: 10. 3109/17435390. 2010. 506250 (2010).
46. Rosen, D. R. et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature362, 59-62 (1993).
47. Elchuri, S. et al. CuZnSOD deficiency leads to persistent and widespread oxidative damage and hepatocarcinogenesis later in life. Oncogene24, 367-380 (2005).
48. Muller, F. L. et al. Absence of CuZn superoxide dismutase leads to elevated oxidative stress and acceleration of age-dependent skeletal muscle atrophy. Free Radic. Biol. Med. 40, 1993-2004 (2006).
49. Sentman, M. L. et al. Phenotypes of mice lacking extracellular superoxide dismutase and copper- and zinccontaining superoxide dismutase. J. Biol. Chem. 281, 6904-6909 (2006).
50. Wu, Y. Z. et al. Interaction of surfactant protein A with peroxiredoxin 6 regulates phospholipase A2 activity. J. Biol. Chem. 281, 7515-7525 (2006).
51. Roede, J. R. et al. In vitro and in silico characterization of peroxiredoxin 6 modified by 4-hydroxynonenal and 4-oxononenal. Chem. Res. Toxicol. 21, 2289-2299 (2008).
52. Manevich, Y. et al. Binding of peroxiredoxin 6 to substrate determines differential phospholipid hydroperoxide peroxidase and phospholipase A(2) activities. Biochem. Biophys. 485, 139-149 (2009).
53. 2+ homeostasis. Brain Res. 1233, 63-78 (2008).
54. Foldbjerg, R. et al. PVP-coated silver nanoparticles and silver ions induce reactive oxygen species, apoptosis and necrosis in THP-1 monocytes. Toxicol. Lett. 190, 156-162 (2009).
55. Engle, S. J. et al. Adenine phosphoribosyltransferasedeficient mice develop 2, 8-dihydroxyadenine nephrolithiasis. Proc. Natl. Acad. Sci. 93, 5307-5312 (1996).
56. Kim, W. Y., Kim, J., Park, J. D., Ryu, H. Y. & Yu, I. J. Histological study of gender differences in accumulation of silver nanoparticles in kidneys of fischer 344 rats. J. Toxicol. Environ. Health Part A72, 1279-1284 (2009).
57. Cederholm, A. & Frostegård, J. Annexin A5 as a novel player in prevention of atherothrombosis in SLE and in the general population. Ann. NY Acad. Sci. 1108, 96-103 (2007).
58. Schlaepfer, D. D., Jones, J. & Haigler, H. T. Inhibition of protein kinase C by annexin V. Biochem. 31, 1886-1891 (1992).
59. Zeglen, S., Zakliczyński, M., Nozyński, J., Rogala, B. & Zembala, M. sCD30, interleukin-1beta-converting enzyme and anti-Annexin V autoantibodies concentrations in heart transplant recipients. Transpl. Immunol. 16, 227-231 (2006).
60. Horio, Y. et al. Rat cytosolic aspartate aminotranferase: molecular cloning of cDNA and expression in Escherichia coli. J. Biochem. 103, 797-804 (1988).
61. Tordjman, J. et al. Cytosolic aspartate aminotransferase, a new partner in adipocyte glyceroneogenesis and an atypical target of thiazolidinedione. J. Biol. Chem. 282, 23591-23602 (2007).
62. Zafar, M., Naqvi, S. N. H., Ahmed, M. & Kaimkhani, Z. A. Altered kidney morphology and enzymes in streptozotocin induced diabetic rats. Int. J. Morphol. 27, 783-790 (2009).
63. Aperia, A., Broberger, O., Larsson, A. & Snellman, K. Studies of renal urea cycle enzymes. I. Renal concentrating ability and urea cycle enzymes in the rat during protein deprivation. Scand. J. Clin. Lab. Invest. 39, 329-336 (1979).
64. Barceló-Batllori, S. et al. Proteomic analysis of cytokine induced proteins in human intestinal epithelial cells: implications for inflammatory bowel diseases. Proteomics2, 551-560 (2002).
65. Kim, E., Maeng, J. H., Lee, D. H. & Kim, J. M. Correlation of biomarkersand histological responses in manufactured silver nanoparticle toxicity. Toxicol. Environ. Health Sci. 1, 17-23 (2009).
66. Langbein, S. et al. Metastasis is promoted by a bioenergetic switch: new targets for progressive renal cell cancer. Int. J. Cancer122, 2422-2428 (2008).
67. Boros, L. G. et al. Nonoxidative pentose phosphate pathways and their direct role in ribose synthesis in tumors: is cancer a disease of cellular glucose metabolism?Med. Hypotheses50, 55-59 (1998).
68. Steer, K. A., Sochor, M., Gonzalez, A. M. & Patricia, M. Regulation of pathways of glucose metabolism in kidney: Specific linking of pentose phosphate pathway activity with kidney growth in experimental diabetes and unilateral nephrectomy. FEBS Lett. 150, 494-498 (1982).
69. Frisell, W. R. & Mackenzie, C. G. Separation and purification of sarcosine dehydrogenase and dimethylglycine dehydrogenase. J. Biol. Chem. 237, 94-98 (1962).
70. Lang, H., Polster, M. & Brandsch, R. Rat liver dimethylglycine dehydrogenase. Flavinylation of the enzyme in hepatocytes in primary culture and characterization of a cDNA clone. Eur. J. Biochem. 198, 793-799 (1991).
71. Hoskins, D. D. & Mackenzie, C. G. Solubilization and electron transfer flavoprotein requirement of mitochondrial sarcosine dehydrogenase and dimethylglycine dehydrogenase. J. Biol. Chem. 236, 177-183 (1961).
72. Cook, R. J., Misono, K. S. & Wagner, C. The amino acid sequences of the flavin-peptides of dimethylglycine dehydrogenase and sarcosine dehydrogenase from rat liver mitochondria. J. Biol. Chem. 260, 12998-13002 (1985).
73. Binzak, B. A. et al. Cloning of dimethylglycine dehydrogenase and a new human inborn error of metabolism, dimethylglycine dehydrogenase deficiency. Am. J. Hum. Genet. 68, 839-847 (2001).
74. Moolenaar, S. H. et al. Defect in dimethylglycine dehydrogenase, a new inborn error of metabolism: NMR spectroscopy study. Clin. Chem. 45, 459-464 (1999).
75. Urban, P., Chirat, I. & Lederer, F. Rat kidney L-2-hydroxyacid oxidase. Structural and mechanistic comparison with flavocytochrome b2 from baker's yeast. Biochem. 27, 7365-7371 (1988).
76. Diêp Lê, K. H. & Lederer, F. Amino acid sequence of long chain alpha-hydroxy acid oxidase from rat kidney, a member of the family of FMN-dependent alphahydroxy acid-oxidizing enzymes. J. Biol. Chem. 266, 20877-20881 (1991).
77. Risérus, U., Willett, W. C. & Hu, F. B. Dietary fats and prevention of type 2 diabetes. Prog. Lipid Res. 48, 44-51 (2009).
78. Fielden, M. R. et al. A gene expression signature that predicts the future onset of drug-induced renal tubular toxicity. Toxicol. Pathol. 33, 675-683 (2005).
79. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities utilizing the principle of protein dye binding. Anal. Biochem. 72, 248-254 (1976).
80. Rabilloud, T. et al. Two-dimensional electrophoresis of human placental mitochondria and protein identification by mass spectrometry: toward a human mitochondrial proteome. Electrophoresis19, 1006-1014 (1998).
81. Oakley, B. R., Kirsch, D. R. & Morris, N. R. Experimentally improved reliability of ultrasensitive silver staining of protein in polyacrylamide gels. Anal. Biochem. 105, 361-363 (1980).
82. Shevchenko, A., Wilm, M., Vorm, O. & Mann, M. Mass spectrometric sequencing of proteins from silverstained polyacrylamide gels. Anal. Chem. 68, 850-858 (1996).